Agah Ramtin 4
4 · RenovoRx, Inc. · Filed Jan 2, 2026
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Agah Ramtin
DirectorChief Medical Officer
Transactions
- Purchase
Common Stock
2025-12-30$0.83/sh+205$169→ 778,665 total
Footnotes (2)
- [F1]Reflects open market purchases of the Issuer's securities.
- [F2]Reflects a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $0.825 to $0.873.